Reading up on other treatment targets for severe Covid-19 being tested.
Lessons from arthritis and cell therapy in cancer patients point to therapy for severe disease https://science.sciencemag.org/content/early/
The resulting increased systemic cytokine production contributes to the pathophysiology of severe COVID-19, including hypotension and acute respiratory distress syndrome (ARDS), which might be treated with IL-6 antagonists such as tocilizumab, sarilumab, and siltuximab.
( These appear to be Injection or IV type treatments )
